Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene
Autor: | Bernard Belhassen, Michael Arad, Michael Eldar, David Luria, Sami Viskin, Rami Fogelman, Eyal Nof, Michael Glikson, Charles Antzelevitch, Raphael Rosso, Dalia El-Ani, Zahurul A. Bhuiyan, Arthur A.M. Wilde, Marcel M.A.M. Mannens |
---|---|
Přispěvatelé: | ACS - Amsterdam Cardiovascular Sciences, ARD - Amsterdam Reproduction and Development, Human Genetics, Cardiology |
Jazyk: | angličtina |
Rok vydání: | 2011 |
Předmět: |
Adult
Male medicine.medical_specialty Adolescent medicine.medical_treatment Long QT syndrome Mutation Missense Catecholaminergic polymorphic ventricular tachycardia Ventricular tachycardia QT interval Ryanodine receptor 2 Article Electrocardiography Physiology (medical) Internal medicine medicine Humans cardiovascular diseases Child Flecainide business.industry Cardiac Pacing Artificial Ryanodine Receptor Calcium Release Channel Implantable cardioverter-defibrillator medicine.disease Defibrillators Implantable Pedigree Death Sudden Cardiac Ventricular fibrillation Cardiology Catheter Ablation Tachycardia Ventricular cardiovascular system Female Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents medicine.drug |
Zdroj: | Heart rhythm, 8(10), 1546-1552. Elsevier Heart Rhythm, vol. 8, no. 10, pp. 1546-1552 |
ISSN: | 1547-5271 |
Popis: | Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhythmogenic disease for which electrophysiological studies (EPS) have shown to be of limited value. Objective This study presents a CPVT family in which marked postpacing repolarization abnormalities during EPS were the only consistent phenotypic manifestation of ryanodine receptor (RyR2) mutation carriers. Methods The study was prompted by the observation of transient marked QT prolongation preceding initiation of ventricular fibrillation during atrial fibrillation in a boy with a family history of sudden cardiac death (SCD). Family members underwent exercise and pharmacologic electrocardiographic testing with epinephrine, adenosine, and flecainide. Noninvasive clinical test results were normal in 10 patients evaluated, except for both epinephrine- and exercise-induced ventricular arrhythmias in 1. EPS included bursts of ventricular pacing and programmed ventricular extrastimulation reproducing short-long sequences. Genetic screening involved direct sequencing of genes involved in long QT syndrome as well as RyR2. Results Six patients demonstrated a marked increase in QT interval only in the first beat after cessation of ventricular pacing and/or extrastimulation. All 6 patients were found to have a heterozygous missense mutation (M4109R) in RyR2. Two of them, presenting with aborted SCD, also had a second missense mutation (I406T- RyR2). Four family members without RyR2 mutations did not display prominent postpacing QT changes. Conclusion M4109R- RyR2 is associated with a high incidence of SCD. The contribution of I406T to the clinical phenotype is unclear. In contrast to exercise testing, marked postpacing repolarization changes in a single beat accurately predicted carriers of M4109R- RyR2 in this family. |
Databáze: | OpenAIRE |
Externí odkaz: |